X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ADCOCK INGRAM
Jun-14
STERLING BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs11366-   
Low Rs3264-   
Sales per share (Unadj.) Rs26.8108.9-  
Earnings per share (Unadj.) Rs-15.0-27.4-  
Cash flow per share (Unadj.) Rs-5.5-22.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.985.5-  
Shares outstanding (eoy) m267.87168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 9.0%   
Avg P/E ratio x-0.5-11.5 4.0%  
P/CF ratio (eoy) x-1.3-13.9 9.2%  
Price / Book Value ratio x0.13.7 3.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86253,186 3.5%   
No. of employees `0001.44.3 31.5%   
Total wages/salary Rs m5473,338 16.4%   
Avg. sales/employee Rs Th5,303.34,281.9 123.9%   
Avg. wages/employee Rs Th403.8777.6 51.9%   
Avg. net profit/employee Rs Th-2,959.0-1,078.9 274.3%   
INCOME DATA
Net Sales Rs m7,18118,382 39.1%  
Other income Rs m43129 33.1%   
Total revenues Rs m7,22318,511 39.0%   
Gross profit Rs m947-3,185 -29.7%  
Depreciation Rs m2,543793 320.6%   
Interest Rs m4,377498 879.1%   
Profit before tax Rs m-5,931-4,348 136.4%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924272 -708.3%   
Profit after tax Rs m-4,007-4,632 86.5%  
Gross profit margin %13.2-17.3 -76.1%  
Effective tax rate %32.4-6.2 -519.3%   
Net profit margin %-55.8-25.2 221.4%  
BALANCE SHEET DATA
Current assets Rs m14,33513,463 106.5%   
Current liabilities Rs m49,8097,575 657.5%   
Net working cap to sales %-494.032.0 -1,542.2%  
Current ratio x0.31.8 16.2%  
Inventory Days Days403111 363.7%  
Debtors Days Days171124 137.7%  
Net fixed assets Rs m55,4327,848 706.4%   
Share capital Rs m26885 313.9%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,70114,428 101.9%   
Long term debt Rs m9,4785,070 186.9%   
Total assets Rs m73,98827,255 271.5%  
Interest coverage x-0.4-7.7 4.6%   
Debt to equity ratio x0.60.4 183.5%  
Sales to assets ratio x0.10.7 14.4%   
Return on assets %0.5-15.2 -3.3%  
Return on equity %-27.3-32.1 84.9%  
Return on capital %-6.4-19.8 32.4%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,7191,569 109.5%  
From Investments Rs m-3,148-482 653.5%  
From Financial Activity Rs m1,4264,602 31.0%  
Net Cashflow Rs m-35,689 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.05 Rs / ZAR

Compare STERLING BIOTECH With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: LUPIN LTD  FULFORD INDIA  CIPLA  J.B.CHEMICALS  PFIZER  



Today's Market

Sensex Trades Marginally Higher; Yes Bank & Tata Motors Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS